HAYWARD, Calif., July 10, 2012 /PRNewswire/ -- Solta Medical,
Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics
market, today announced that it will release its financial results
for the second quarter ended June 30,
2012, after market close on Thursday,
July 26, 2012. The Company will also host a conference
call and webcast on Thursday, July 26,
2012, at 4:30 p.m. Eastern
Time (1:30 p.m. Pacific) to
discuss the financial results and current corporate
developments. The dial-in number for the conference call is
877-941-9205 for domestic participants and 480-629-9819 for
international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers six aesthetic energy devices to
address a range of issues, including skin resurfacing and
rejuvenation with Fraxel® and Clear + Brilliant™, body contouring
and skin tightening with Liposonix® and Thermage® and acne
reduction with Isolaz® and CLARO™. As the innovator and leader in
fractional laser technology, Fraxel delivers minimally invasive
clinical solutions to resurface aging and sun-damaged skin. Using
similar fractional laser technology, Clear + Brilliant is a unique,
cost-effective treatment to prevent and improve the early signs of
photoaging. For body contouring, Liposonix is a non-surgical
treatment to reduce waist circumference with advanced
high-intensity focused ultrasound (HIFU) technology to permanently
destroy targeted fat beneath the skin. Thermage is an innovative,
non-invasive radiofrequency procedure for tightening and contouring
skin. Isolaz was the first laser or light-based system indicated
for the treatment of inflammatory acne, comedonal acne, pustular
acne and mild-to-moderate inflammatory acne. CLARO is a personal
care acne system that is the first FDA-cleared over-the-counter IPL
device that uses a powerful combination of both heat and light to
clear skin quickly and naturally. More than two million procedures
have been performed with Solta Medical's portfolio of products
around the world. For more information about Solta Medical, call
1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage,
Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta
Medical are trademarks or registered trademarks of Solta Medical,
Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.